R E S E A R C H G R A N T S & CO N T R AC T S AWA R D E D I N 2019
FEDERAL RESEARCH GRANTS
PRINCIPAL INVESTIGATOR
LENGTH
PROJECT TOTAL
NATIONAL INSTITUTES OF HEALTH (NIH) – Establishment of a SPF Rhesus Macaque Colony
Dr. Deepak Kaushal
4 years
$9,299,924
NIH – Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
Dr. Viraj Kulkarni
2 years
$8,120,959
NIH – SigH based attenuated, efficacious M.tb vaccines to protect against lethal TB
Dr. Deepak Kaushal
4 years
$4,214,613
NIH – Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function
Dr. Deepak Kaushal
3 years
$3,299,986
NIH – Immune Correlates of Protection from TB
Dr. Deepak Kaushal
4 years
$3,237,501
NIH/UOHSC – Strong Heart Study Coordinating Center
Dr. Shelley Cole
6 years
$3,097,542
NIH – Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
Dr. Larry Schlesinger
4 years
$2,856,798
NIH/STONYBROOK U – Cannabinoid modulation of extracellular vesicle composition and function in HIV/SIV infection
Dr. Mahesh Mohan
5 years
$2,315,013
NIH/HMRI – A Neonatal Monkey Model of Tuberculosis Vaccination
Dr. Marie-Claire Gauduin
3 years
$2,251,269
NIH/BCH – Optimizing and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine
Dr. Deepak Kaushal
4 years
$1,532,253
CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAM – Zika Virus Countermeasures: Preclinical Pregnancy Models to Assess Protective Efficacy Against Placental Damage and Fetal Demise
Dr. Jean Patterson
3 years
$1,233,890
NIH – Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection
Dr. Deepak Kaushal
2 years
$1,077,111
NIH/TRINITY – Marmosets as a Model for Understanding Social, Neuroendocrine, and Vascular Contributions to Cognitive Aging
Dr. Corinna Ross
5 years
$701,089
NIH/UWASH – Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
Dr. Deepak Kaushal
4 years
$645,830
NIH/TULANE – Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
Dr. Deepak Kaushal
5 years
$614,381
NIH/WUSL – Role of inducible bronchus associated lymphoid tissue in latent Tuberculosis
Dr. Deepak Kaushal
2 years
$561,462
NIH/UCSC – Nanopore-based multi-target analysis of Zika virus infection
Dr. Jean Patterson
4 years
$508,195
NIH – Expansion of Marmoset Breeding Facilities to Meet Increasing Research Demands (SNPRC Supplement)
Dr. Larry Schlesinger
1 year
$499,999
NIH – Role of chronic immune activation reactivating latent tuberculosis infection during M. tuberculosis/SIV co-infection: implications for anti-retroviral and anti-TB therapies (SNPRC Supplement)
Dr. Larry Schlesinger
2 years
$499,998
NIH – Development of resources to assess ambulation and sensory systems for marmoset AD/dementia research (SNPRC Supplement)
Dr. Corinna Ross
1 year
$423,597
NIH/WUSL – Common immune correlates of risk of TB disease in animal models and humans
Dr. Deepak Kaushal
3 years
$290,964
NIH – Exploring the impact of inflammaging on immune function during M. tb infection (Admin Supplement)
Dr. Joanne Turner
1 year
$289,900
NIH/EMORY – Role of Antigen Specific T Cell Responses in the Control of TB
Dr. Deepak Kaushal
3 years
$287,231
NIH/WUSOM – Population genomics and new tools for the endgame of onchocerciasis elimination in Africa
Dr. Timothy Anderson
5 years
$254,786
BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY/JANSSEN – ELIspot and ICS analysis of Non-Human Primate samples generated under Janssen (DS-REF-129289: Immunogenicity of SLA-LSQ adjuvant formulations in non-human primates)
Dr. Luis Giavedoni
1 year
$223,697
SPONSOR AND TITLE
16